Table 1 Characteristics of patients and controls
Patients (n = 36) | Controls (n = 76) | |||
|---|---|---|---|---|
Baseline | Follow-up | Baseline | Follow-up | |
Gender (n, women/men) | 8/28 | 8/28 | 29/47 | 29/47 |
Age (year) | 39.4 | 44.4 | 41.1 | 47.5§ |
Education (year) | 12.6 | NA | 14.0§ | NA |
WAIS verbal IQ | 87.3 | NA | 103.0*** | NA |
GAF | 49.2 | 48.3 | 87.3*** | 83.9*** |
SANS composite score | 28.9 | 33.4 | NA | NA |
SAPS composite score | 10.0 | 11.1 | NA | NA |
Medication (mg, CPZ-equivalents) | 208.9 | 263.3 | NA | NA |
Medication-no antipsychotics (n) | 4 | 5 | NA | NA |
Medication-2nd gen antipsychotics (n) | 14 | 15 | NA | NA |
Medication-1st gen antipsychotics (n) | 16 | 9 | NA | NA |
Medication-1st and 2nd gen antipsychotics (n) | 2 | 7 | NA | NA |